According to recent literature, DYRK1A appears to be involved in various diseases, including Alzheimer’s disease (AD), Down syndrome (DS) [4], and cancer [5,6,7], and many efforts have evolved over the last five years toward the identification of potent and selective DYRK1A inhibitors [8,9]. Here, DYRK1A is linked to cancer.